FDA TEMPO Selected Dexcom: What the Pilot Does and Does Not Mean
FDA lists Dexcom and Cadence Solutions in its TEMPO pilot, but selection is not approval and the agency says effectiveness for the pilot uses has not yet been evaluated.
PATech Labs News
What's happening with AI in business: facts, primary sources, and named authors. In English, Russian, and Spanish.
FDA lists Dexcom and Cadence Solutions in its TEMPO pilot, but selection is not approval and the agency says effectiveness for the pilot uses has not yet been evaluated.
HHS guidance separates permitted appointment reminders from the privacy safeguards that shape their content and delivery.
In 2026 the FDA cleared the first clinical language model allowed to speak directly with a patient. A fresh funding wave and a new Medicare pathway show that regulated, voice-first healthcare AI is now shippable.
The most life-saving AI in medicine is quiet and invisible to the patient. It does not replace doctors; it catches disease earlier and extends scarce expertise where no specialist exists.